M&A / Deals Shionogi secures $482m BARDA contract to tackle AMR crisis Pharmaceutical TechnologyShionogi will use the money from BARDA to build an American antibiotic manufacturing site as the US looks to fight antimicrobial resistance.M&A / DealsInfectious DiseaseRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaceutical Technology Shionogi will use the money from BARDA to build an American antibiotic manufacturing site as the US looks to fight antimicrobial resistance. M&A / DealsInfectious DiseaseRead full story Post navigation Previous: Sidewinder secures $137M to advance ‘precision’ ADCsNext: Syneron raises $150m for macrocyclics, and other financings Related Stories M&A / Deals Exegenesis Bio and Modalis sign research deal for Duchenne therapy pharminent September 11, 2026 M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026